Study 19 of 2431 for search of: received on or after 11/14/2008
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)
This study is currently recruiting participants.
Study NCT00819000.   Last updated on January 7, 2009.
Information provided by Teva Pharmaceutical Industries
Please refer to this study by its ClinicalTrials.gov identifier: NCT00819000
Locations
United States, Illinois
(3) Walgreen Co. and its specialty pharmacy subsidiaries and affiliates, Not yet recruiting
Deerfield, Illinois, United States, 60015
United States, Michigan
Diplomat Specialty Pharmacy Recruiting
Swartz Creek, Michigan, United States, 48473
Contact: Cora L Edwards, BA, CCRP     810-720-6851     cedwards@diplomatpharmacy.com    
United States, Ohio
BioScrip, Inc. Not yet recruiting
Columbus, Ohio, United States, 43228
Contact: Kira Botkin, BA     614-850-1230     kbotkin@bioscrip.com    
Sponsors and Collaborators
Teva Pharmaceutical Industries
Investigators
Study Chair: MerriKay Oleen-Burkey, PhD Teva Neuroscience, Inc.
Study Director: Howard Zwibel, MD Neurologic Center of South Florida




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services